EDIT-101
1991-201-008
Phase 2 small_molecule active
Quick answer
EDIT-101 for Leber Congenital Amaurosis 10 is a Phase 2 program (small_molecule) at Editas Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Editas Medicine
- Indication
- Leber Congenital Amaurosis 10
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active